ResMed Total Assets from 2010 to 2024
| RMD Stock | USD 180.35 1.50 0.84% |
Total Assets | First Reported 1993-06-30 | Previous Quarter 6.7 B | Current Value 6.9 B | Quarterly Volatility 1.8 B |
Check ResMed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ResMed main balance sheet or income statement drivers, such as Depreciation And Amortization of 238.6 M, Interest Expense of 57.2 M or Total Revenue of 5.1 B, as well as many exotic indicators such as Price To Sales Ratio of 4.25, Dividend Yield of 0.0183 or PTB Ratio of 4.78. ResMed financial statements analysis is a perfect complement when working with ResMed Valuation or Volatility modules.
ResMed | Total Assets |
Latest ResMed's Total Assets Growth Pattern
Below is the plot of the Total Assets of ResMed Inc over the last few years. Total assets refers to the total amount of ResMed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ResMed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. ResMed's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ResMed's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 6.75 B | 10 Years Trend |
|
Total Assets |
| Timeline |
ResMed Total Assets Regression Statistics
| Arithmetic Mean | 3,991,883,507 | |
| Geometric Mean | 2,485,153,485 | |
| Coefficient Of Variation | 56.57 | |
| Mean Deviation | 1,765,961,474 | |
| Median | 3,468,487,000 | |
| Standard Deviation | 2,258,212,585 | |
| Sample Variance | 5099524.1T | |
| Range | 8.1B | |
| R-Value | 0.96 | |
| Mean Square Error | 457879.2T | |
| R-Squared | 0.92 | |
| Slope | 483,443,407 | |
| Total Sum of Squares | 71393337.1T |
ResMed Total Assets History
Other Fundumenentals of ResMed Inc
ResMed Total Assets component correlations
Click cells to compare fundamentals
About ResMed Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include ResMed income statement, its balance sheet, and the statement of cash flows. ResMed investors use historical funamental indicators, such as ResMed's Total Assets, to determine how well the company is positioned to perform in the future. Although ResMed investors may use each financial statement separately, they are all related. The changes in ResMed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ResMed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ResMed Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ResMed. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 7.8 B | 8.2 B | |
| Intangibles To Total Assets | 0.44 | 0.47 |
Currently Active Assets on Macroaxis
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out the analysis of ResMed Correlation against competitors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 1.84 | Earnings Share 6.05 | Revenue Per Share 30.633 | Quarterly Revenue Growth 0.125 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.